3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine

C209H270F12N32O2 — CID 158682605

IUPAC3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine
SMILESCC(C)(C)c1c(C(C)(C)O)nn2ccccc12.CC(C)(C)c1c(C(F)(F)F)nn2ccccc12.CC(C)(C)c1c(C2CC2)nn2ccccc12.CC(C)(C)c1c(C2CCC2)nn2ccccc12.CC(C)(C)c1c(C2CCCC2)nn2ccccc12.CC(C)(C)c1c(C2CCOCC2)nn2ccccc12.CC(C)(C)c1nc(C(F)(F)F)c2ccccn12.CC(C)(C)c1nc(C(F)(F)F)n2ccccc12.CCc1nn2ccccc2c1C(C)(C)C.Cc1cccc2c(C(C)(C)C)c(C(F)(F)F)nn12.Cc1nc(C(C)(C)C)c2ccccn12.Cc1nc(C(C)(C)C)n2ccccc12.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C
InChIInChI=1S/C16H22N2O.C16H22N2.C15H20N2.C14H20N2O.C14H18N2.C13H15F3N2.C13H18N2.3C12H13F3N2.6C12H16N2/c1-16(2,3)14-13-6-4-5-9-18(13)17-15(14)12-7-10-19-11-8-12;1-16(2,3)14-13-10-6-7-11-18(13)17-15(14)12-8-4-5-9-12;1-15(2,3)13-12-9-4-5-10-17(12)16-14(13)11-7-6-8-11;1-13(2,3)11-10-8-6-7-9-16(10)15-12(11)14(4,5)17;1-14(2,3)12-11-6-4-5-9-16(11)15-13(12)10-7-8-10;1-8-6-5-7-9-10(12(2,3)4)11(13(14,15)16)17-18(8)9;1-5-10-12(13(2,3)4)11-8-6-7-9-15(11)14-10;1-11(2,3)10-16-9(12(13,14)15)8-6-4-5-7-17(8)10;1-11(2,3)9-8-6-4-5-7-17(8)10(16-9)12(13,14)15;1-11(2,3)9-8-6-4-5-7-17(8)16-10(9)12(13,14)15;1-9-13-11(12(2,3)4)10-7-5-6-8-14(9)10;4*1-9-11(12(2,3)4)10-7-5-6-8-14(10)13-9;1-9-10-7-5-6-8-14(10)11(13-9)12(2,3)4/h4-6,9,12H,7-8,10-11H2,1-3H3;6-7,10-12H,4-5,8-9H2,1-3H3;4-5,9-11H,6-8H2,1-3H3;6-9,17H,1-5H3;4-6,9-10H,7-8H2,1-3H3;5-7H,1-4H3;6-9H,5H2,1-4H3;3*4-7H,1-3H3;6*5-8H,1-4H3
InChIKeyIFIAVDCTFDRXCM-UHFFFAOYSA-N
MW3490.66 g/mol
LogP53.83
Rot. Bonds6

About 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine

3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine (PubChem CID 158682605) has the molecular formula C209H270F12N32O2 and a molecular weight of 3490.66 g/mol. Its IUPAC name is 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine.

Molecular Properties

Compound Name3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine
PubChem CID158682605
Molecular FormulaC209H270F12N32O2
Molecular Weight3490.66 g/mol
Exact Mass3488.18
IUPAC Name3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine
SMILESCC(C)(C)c1c(C(C)(C)O)nn2ccccc12.CC(C)(C)c1c(C(F)(F)F)nn2ccccc12.CC(C)(C)c1c(C2CC2)nn2ccccc12.CC(C)(C)c1c(C2CCC2)nn2ccccc12.CC(C)(C)c1c(C2CCCC2)nn2ccccc12.CC(C)(C)c1c(C2CCOCC2)nn2ccccc12.CC(C)(C)c1nc(C(F)(F)F)c2ccccn12.CC(C)(C)c1nc(C(F)(F)F)n2ccccc12.CCc1nn2ccccc2c1C(C)(C)C.Cc1cccc2c(C(C)(C)C)c(C(F)(F)F)nn12.Cc1nc(C(C)(C)C)c2ccccn12.Cc1nc(C(C)(C)C)n2ccccc12.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C
InChIInChI=1S/C16H22N2O.C16H22N2.C15H20N2.C14H20N2O.C14H18N2.C13H15F3N2.C13H18N2.3C12H13F3N2.6C12H16N2/c1-16(2,3)14-13-6-4-5-9-18(13)17-15(14)12-7-10-19-11-8-12;1-16(2,3)14-13-10-6-7-11-18(13)17-15(14)12-8-4-5-9-12;1-15(2,3)13-12-9-4-5-10-17(12)16-14(13)11-7-6-8-11;1-13(2,3)11-10-8-6-7-9-16(10)15-12(11)14(4,5)17;1-14(2,3)12-11-6-4-5-9-16(11)15-13(12)10-7-8-10;1-8-6-5-7-9-10(12(2,3)4)11(13(14,15)16)17-18(8)9;1-5-10-12(13(2,3)4)11-8-6-7-9-15(11)14-10;1-11(2,3)10-16-9(12(13,14)15)8-6-4-5-7-17(8)10;1-11(2,3)9-8-6-4-5-7-17(8)10(16-9)12(13,14)15;1-11(2,3)9-8-6-4-5-7-17(8)16-10(9)12(13,14)15;1-9-13-11(12(2,3)4)10-7-5-6-8-14(9)10;4*1-9-11(12(2,3)4)10-7-5-6-8-14(10)13-9;1-9-10-7-5-6-8-14(10)11(13-9)12(2,3)4/h4-6,9,12H,7-8,10-11H2,1-3H3;6-7,10-12H,4-5,8-9H2,1-3H3;4-5,9-11H,6-8H2,1-3H3;6-9,17H,1-5H3;4-6,9-10H,7-8H2,1-3H3;5-7H,1-4H3;6-9H,5H2,1-4H3;3*4-7H,1-3H3;6*5-8H,1-4H3
InChIKeyIFIAVDCTFDRXCM-UHFFFAOYSA-N
XLogP53.83
TPSA306.26 Ų
H-Bond Donors1
H-Bond Acceptors34
Rotatable Bonds6
Heavy Atoms255
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003490.66
LogP ≤ 553.83
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1034

Analyze 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine?
The IUPAC name of 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine (CID 158682605) is 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine.
What is the SMILES notation for 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine?
The canonical SMILES for 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine is CC(C)(C)c1c(C(C)(C)O)nn2ccccc12.CC(C)(C)c1c(C(F)(F)F)nn2ccccc12.CC(C)(C)c1c(C2CC2)nn2ccccc12.CC(C)(C)c1c(C2CCC2)nn2ccccc12.CC(C)(C)c1c(C2CCCC2)nn2ccccc12.CC(C)(C)c1c(C2CCOCC2)nn2ccccc12.CC(C)(C)c1nc(C(F)(F)F)c2ccccn12.CC(C)(C)c1nc(C(F)(F)F)n2ccccc12.CCc1nn2ccccc2c1C(C)(C)C.Cc1cccc2c(C(C)(C)C)c(C(F)(F)F)nn12.Cc1nc(C(C)(C)C)c2ccccn12.Cc1nc(C(C)(C)C)n2ccccc12.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C.Cc1nn2ccccc2c1C(C)(C)C.
What is the InChIKey of 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine?
The InChIKey is IFIAVDCTFDRXCM-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H22N2O.C16H22N2.C15H20N2.C14H20N2O.C14H18N2.C13H15F3N2.C13H18N2.3C12H13F3N2.6C12H16N2/c1-16(2,3)14-13-6-4-5-9-18(13)17-15(14)12-7-10-19-11-8-12;1-16(2,3)14-13-10-6-7-11-18(13)17-15(14)12-8-4-5-9-12;1-15(2,3)13-12-9-4-5-10-17(12)16-14(13)11-7-6-8-11;1-13(2,3)11-10-8-6-7-9-16(10)15-12(11)14(4,5)17;1-14(2,3)12-11-6-4-5-9-16(11)15-13(12)10-7-8-10;1-8-6-5-7-9-10(12(2,3)4)11(13(14,15)16)17-18(8)9;1-5-10-12(13(2,3)4)11-8-6-7-9-15(11)14-10;1-11(2,3)10-16-9(12(13,14)15)8-6-4-5-7-17(8)10;1-11(2,3)9-8-6-4-5-7-17(8)10(16-9)12(13,14)15;1-11(2,3)9-8-6-4-5-7-17(8)16-10(9)12(13,14)15;1-9-13-11(12(2,3)4)10-7-5-6-8-14(9)10;4*1-9-11(12(2,3)4)10-7-5-6-8-14(10)13-9;1-9-10-7-5-6-8-14(10)11(13-9)12(2,3)4/h4-6,9,12H,7-8,10-11H2,1-3H3;6-7,10-12H,4-5,8-9H2,1-3H3;4-5,9-11H,6-8H2,1-3H3;6-9,17H,1-5H3;4-6,9-10H,7-8H2,1-3H3;5-7H,1-4H3;6-9H,5H2,1-4H3;3*4-7H,1-3H3;6*5-8H,1-4H3.
What are the key properties of 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine?
3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine has a molecular weight of 3490.66 g/mol, XLogP of 53.83, 6 rotatable bonds, 1 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 3-tert-butyl-2-cyclobutylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopentylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-cyclopropylpyrazolo[1,5-a]pyridine;3-tert-butyl-2-ethylpyrazolo[1,5-a]pyridine;1-tert-butyl-3-methylimidazo[1,5-a]pyridine;3-tert-butyl-1-methylimidazo[1,5-a]pyridine;tetrakis(3-tert-butyl-2-methylpyrazolo[1,5-a]pyridine);3-tert-butyl-7-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine;3-tert-butyl-2-(oxan-4-yl)pyrazolo[1,5-a]pyridine;2-(3-tert-butylpyrazolo[1,5-a]pyridin-2-yl)propan-2-ol;1-tert-butyl-3-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-1-(trifluoromethyl)imidazo[1,5-a]pyridine;3-tert-butyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine is sourced from PubChem (CID 158682605), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).